Eduardo Tolosa And NotEspagne

List of bibliographic references

Number of relevant bibliographic references: 5.

Ident.	Authors (with country if any)	Title
000237	Andrew J. Lees [Royaume-Uni] ; Eduardo Tolosa ; C Warren Olanow	Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
000386	Gesine Respondek [Allemagne] ; Maria Stamelou ; Carolin Kurz ; Leslie W. Ferguson ; Alexander Rajput ; Wan Zheng Chiu ; John C. Van Swieten ; Claire Troakes ; Safa Al Sarraj ; Ellen Gelpi ; Carles Gaig ; Eduardo Tolosa ; Wolfgang H. Oertel ; Armin Giese ; Sigrun Roeber ; Thomas Arzberger ; Stefan Wagenpfeil ; Günter U. Höglinger	The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
000B23	Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder	AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
000C64	Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Maral Mouradian ; Wolfgang H. Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar	Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.
000E11	Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. Moline	Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024